SCHEMBL14928587

SCHEMBL14928587

CCCC[C@@H](Nc1nc(Cl)c(C#N)cc1F)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.42
TRPV3 Q8NET8 3/20 0.35
PGK1 P00558 1/20 0.33
POLB P06746 2/20 0.33
JAK3 P52333 3/20 0.32
JAK2 O60674 2/20 0.32
LIMK1 P53667 1/20 0.32
LIMK2 P53671 1/20 0.32
CDK2 P24941 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PKM P14618 1/20 0.31
AR P10275 1/20 0.31
IDH1 O75874 2/20 0.31
MUSK O15146 1/20 0.31
NTRK1 P04629 1/20 0.31
LCK P06239 1/20 0.31
RET P07949 1/20 0.31
FGFR3 P22607 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14928686 0.93 KHK (0.43) KHKTRPV3PGK1POLBJAK3
SCHEMBL14928701 0.88 KHK (0.46) KHKTRPV3PGK1POLBJAK3
SCHEMBL14928731 0.88 KHK (0.46) KHKTRPV3PGK1POLBJAK3
SCHEMBL16760787 0.85 KHK (0.36) KHKPOLBJAK3JAK2LIMK1
SCHEMBL16760786 0.85 KHK (0.36) KHKPOLBJAK3JAK2LIMK1
SCHEMBL16169044 0.85 KHK (0.41) KHKTRPV3PGK1JAK3JAK2
SCHEMBL14928839 0.84 KHK (0.43) KHKPGK1POLBALDH1A1PKM
SCHEMBL14911090 0.84 KHK (0.48) KHKTRPV3PGK1JAK3JAK2
SCHEMBL14685133 0.84 KHK (0.44) KHKTRPV3CYP1A2CYP2C9CYP2C19
SCHEMBL14911089 0.84 KHK (0.48) KHKTRPV3PGK1JAK3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051310-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2015-06-09 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK KHK 2008/4885TRPV3 1017/4885PGK1 4462/4885
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 KHK 1750/4885TRPV3 1916/4885PGK1 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.